Vaccine Preventable Diseases: Part 1: Vaccine Preventable Disease Surveillance

2008 ◽  
pp. 229-253 ◽  
Author(s):  
Hanna Nohynek ◽  
Elizabeth Miller
2020 ◽  
Vol 30 (Supplement_5) ◽  
Author(s):  
F Magurano ◽  
M Baggieri ◽  
P Bucci ◽  
E D'Ugo ◽  
M Sabbatucci ◽  
...  

Abstract Background Measles is a vaccine-preventable infectious disease and it remains one of the leading causes of infant mortality globally. The World Health Organization (WHO) has adopted the goal of eliminating measles and rubella. Detection and control of communicable diseases would not be possible without accurate laboratory results regarding when and where a particular disease circulates. Methods WHO/Europe therefore works with all Member States to steadily improve the quality of the laboratory data in order to determine the Region's progress towards measles and rubella elimination. For this purpose coordinates the European Measles and Rubella Laboratory Network (MR LabNet). National labs in this network undergoes regular external quality assessment through an annual accreditation programme. Results In Italy, a Sub-national Reference Laboratories Network for measles and rubella (MoRoNET) has been developed since March 2017 and currently includes 15 laboratories. MoRoNet was developed following the indications of the MR LabNet. It is accreditate, coordinated and supervised by the National Reference Laboratory. Conclusions Strengthening the role of national laboratories in overseeing the performance of subnational laboratories has become a critical need in order to properly monitor the Region's measles and rubella elimination efforts. MoRoNet permits to Italy to develop a country-specific work plan for establishing national networks and oversight mechanism, including preliminary monitoring and evaluation indicators compliant with MR LabNet standards. This is very significant not only to optimize the participation in national and regional processes to verify disease elimination, but also to strengthen the quality of vaccine-preventable disease surveillance. MoRoNet Group: A Amendola; F Baldanti; MR Capobianchi; M Chironna; MG Cusi; P D'Agaro; P Lanzafame; T Lazzarotto; K Marinelli; A Orsi; E Pagani; G Palù; F Pittaluga, A Sacchi; F Tramuto. Key messages MoRoNet has permitted to Italy to develop a country-specific work plan for establishing national networks and oversight mechanism, compliant with WHO MR LabNet standards. MoRoNet network has permitted to optimize the participation in processes to verify disease elimination, but also to strengthen the quality of vaccine-preventable disease surveillance.


2016 ◽  
Vol 6 (1) ◽  
Author(s):  
Eileen M. Dunne ◽  
Silivia Mantanitobua ◽  
Shalini P. Singh ◽  
Rita Reyburn ◽  
Evelyn Tuivaga ◽  
...  

Vaccine ◽  
2013 ◽  
Vol 31 ◽  
pp. C94-C98 ◽  
Author(s):  
Terri B. Hyde ◽  
Jon K. Andrus ◽  
Vance J. Dietz ◽  
Jon K. Andrus ◽  
Terri B. Hyde ◽  
...  

Vaccine ◽  
2013 ◽  
Vol 31 ◽  
pp. C88-C93 ◽  
Author(s):  
C.M. Toscano ◽  
M. Vijayaraghavan ◽  
H.M. Salazar-Bolaños ◽  
H.M. Bolaños-Acuña ◽  
A.I. Ruiz-González ◽  
...  

2021 ◽  
Vol 12 ◽  
pp. 215013272110140
Author(s):  
Oluchi Elekwachi ◽  
La’Marcus T. Wingate ◽  
Veronica Clarke Tasker ◽  
Lorraine Aboagye ◽  
Tadesse Dubale ◽  
...  

Vaccine preventable diseases are responsible for a substantial degree of morbidity in the United States as over 18 million annual cases of vaccine preventable disease occur in the U.S. annually. The morbidity due to vaccine preventable disease is disproportionately borne by adults as over 99% of the deaths due to vaccine preventable diseases occur within adults, and national data indicates that there racial disparities in the receipt of vaccines intended for elderly adults. A literature review was conducted by using the PubMed database to identify research articles that contained information on the vaccination rates among minority populations for selected vaccines intended for use in elderly populations including those for herpes zoster, tetanus, diphtheria, pertussis, hepatitis A, and hepatitis B. A total of 22 articles were identified, 8 of which focused on tetanus related vaccines, 2 of which focused on hepatitis related vaccines, and 12 of which focused on herpes zoster. The findings indicate that magnitude of the disparity for the receipt of tetanus and herpes related vaccines is not decreasing over time. Elderly patients having a low awareness of vaccines and suboptimal knowledge for when or if they should receive specific vaccines remains a key contributor to suboptimal vaccination rates. There is an urgent need for more intervention-based studies to enhance the uptake of vaccines within elderly populations, particularly among ethnic minorities where culturally sensitive and tailored messages may be of use.


Sign in / Sign up

Export Citation Format

Share Document